p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma

This publication has 22 references indexed in Scilit:

• Prognostic and predictive value of p53 and p21 in breast cancer
  Breast Cancer Research and Treatment, 1998
• Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression
  British Journal of Cancer, 1997
• Prognostic Significance of Vascular Endothelial Growth Factor Protein in Node-Negative Breast Carcinoma
  JNCI Journal of the National Cancer Institute, 1997
• Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
  Nature Medicine, 1995
• Tumor Angiogenesis as a Prognostic Assay for Invasive Ductal Breast Carcinoma
  JNCI Journal of the National Cancer Institute, 1995
• Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols
  British Journal of Cancer, 1995
• Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
  Science, 1994
• Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
  Journal of Clinical Oncology, 1994
• Tumor angiogenesis in node-negative breast carcinomas ? relationship with epidermal growth factor receptor, estrogen receptor, and survival
  Breast Cancer Research and Treatment, 1994
• Intratumoral microvessel density and L53 protein: Correlation with metastasis in head‐and‐neck squamous‐cell carcinoma
  International Journal of Cancer, 1993